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Abstract
Leishmaniasis is caused by Leishmania sp., which is transmitted to human beings and
reservoirs by phlebotomine sand flies, with worldwide prevalence of approximately 12
million cases with population at risk of approximately 350 million. Cutaneous leishman-
iasis (CL) is the most widespread form, causing localized skin lesions (LCL), mucocuta-
neous leishmaniasis (MCL), or nodular lesions in diffused cutaneous leishmaniasis
(DCL). American CL includes LCL and DCL caused by Leishmania mexicana complex
and MCL caused by the Leishmania braziliensis complex. In Mexico, CL is distributed in
three endemic areas, Gulf of Mexico, Pacific of Mexico, and Central Mexico. In order to
monitor clinical outcome and adequately target treatment as well as epidemiologic stud-
ies, diagnostic kinetoplast DNA (kDNA), polymerase chain reaction (PCR), Southern and
dot blotting, and ITS1 PCR-RFLP of Leishmania DNA were evaluated in samples and
Leishmania isolates from patients with cutaneous ulcers from several endemic areas. In
Mexico, LCL can be caused by the L. mexicana, L. braziliensis, or both complexes. DCL is
caused by L. (L.) mexicana or Leishmania (L.) amazonensis and visceral leishmaniasis (VL)
by Leishmania (L.) chagasi and L. (L.) mexicana in immunocompromised patients. The
geographic range in which CL is endemic has increased due to urbanization, new settle-
ments, and ecological, social, and educative conditions, which favors its permanence and
transmission.
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1. Introduction
Leishmaniasis is a group of clinical entities present in 79 countries at a rate of 400,000 cases
per year. The World Health Organization estimates a worldwide prevalence of approximately
12 million cases with population at risk of approximately 350 million. It is caused by a parasitic
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protozoan, which belongs to the Leishmania genus that is transmitted to human beings and
animal reservoirs by phlebotomine sand flies [1].
Cutaneous leishmaniasis (CL) is the most widespread form, causing primary localized skin lesions
from which parasites can disseminate to the nasopharyngeal mucosa and cause mucocutaneous
leishmaniasis (MCL) or disseminate to the entire body as nodular lesions in diffused cutaneous
leishmaniasis (DCL). Visceral leishmaniasis (VL) is the most severe form of the disease; according
to the WHO in areas endemic for VL, many people have asymptomatic infection and a concom-
itant HIV infection increases the risk of developing active VL by between 100 and 2320 times [1].
VL is characterized by irregular fever, weight loss, swelling of the liver and spleen, and
anemia. After recovery, patients sometime develop chronic DCL [2, 3].
American cutaneous leishmaniasis is characterized by a spectrum of clinical presentations
caused by Leishmania species grouped in complexes; these include LCL caused by Leishmania
(L.) mexicana; DCL caused by Leishmania amazonensis, Leishmania venezuelensis, and Leishmania
pifanoi, all of them belonging to the L. mexicana complex; and MCL caused by members of the
L. braziliensis complex. VL is caused by L. (L.) chagasi belonging to the L. donovani complex.
Symptomatic diagnosis confuses CL with unrelated disorders such as tropical ulcers, sporotri-
chosis, leprosy, and skin cancer, among others [4].
In Mexico, Seidelin first recorded LCL caused by L. (L.) mexicana in 1912, who called it
“chiclero’s ulcer,” because he found the disease in rubber workers. CL is distributed in three
main endemic areas: Gulf of Mexico, Pacific of Mexico, and Central Mexico. In these regions,
multiple species of Leishmania may coexist and several species can cause both LCL and MCL
[5–7]. Several methods of detection of Leishmania based on deoxyribonucleic acid (DNA) have
been described. The polymerase chain reaction (PCR) has been employed for selective ampli-
fication of Leishmania DNA. Several molecular targets for a diagnostic PCR have been evalu-
ated including the minicircle kinetoplast DNA (kDNA), the miniexon (spliced leader RNA)
gene, and the internal transcribed spacer (ITS) [8–10], among others.
2. Materials and methods
In order to find a diagnostic method for leishmaniasis that combines high sensitivity with
species differentiation in the field, rapid diagnosis, and low cost, several molecular targets for a
diagnostic PCR were evaluated from patients with cutaneous ulcers suspected of having LC
from several endemic areas. The target was minicircle kinetoplast DNA (kDNA) using specific
primers or probes with the PCR and Southern or dot blotting [11] and PCR-RFLP of the
internal transcribed spacer 1 (ITS1) [10, 12].
Distribution of CL or VL in social, educative, and ecological conditions was recorded. The
patients diagnosed with CL were treated with meglumine antimoniate (Glucantime®).
2.1. Patient population
In these studies, we evaluated samples from patients with clinical symptoms and skin lesions
suggestive of CL, MCL, and DCL from several endemic areas of Mexico—Campeche, Tabasco,
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Veracruz, Nayarit and Chiapas, and Quintana Roo—or samples from VL patients from Chia-
pas and Tabasco states. The clinical samples were taken on filter papers or smears, needle
aspirates, and tissue biopsy samples (1–2 mm) from the edge of cutaneous or bone marrow
aspirates (Figure 1).
2.2. Ethical considerations
For bleeding human beings for diagnosis and therapeutics, informed consent was obtained
from all the adults who participated in the study. Consent for including young children was
obtained from their parents or guardians. The ethics committee of the corresponding health
authorities, in agreement with International Ethical Guidelines for Biomedical Research
involving human subjects (Norma Oficial Mexicana de Salud: NOM-003-SSA 2-1993),
reviewed and approved the protocols of the present studies.
2.3. Leishmania reference strains and Mexican isolate culture conditions
Reference Leishmania strains (Table 1), used as control and Mexican isolates of Leishmania from
Tabasco, Veracruz, Campeche, and Quintana Roo states (Table 2 and Figure 1), were cultured in
Roswell Park Memorial Institute medium 1640 (RPMI medium 1640) supplemented with 10%
fetal calf serum at 26°C. DNAs of Trypanosoma cruzi andMycobacterium tuberculosis were used as
negative controls.
Figure 1. Map of Mexico, showing the Ocean Pacific, Gulf of Mexico, and Central Leishmaniasis endemic regions.
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2.4. Isolation of DNA
Clinical specimens cut from the filter paper or eluted from the smear, bone marrow aspirates,
skin aspirates, and tissue biopsy samples (1–2 mm) were incubated in 250 μL of cell lysis buffer
for 1 h at 56°C. DNA from Leishmania cultures was prepared by centrifuging 109 parasites in the
exponential phase of growth at 2000 × g for 10 min at 4°C. The DNA was extracted from the
pellet using the High Pure PCR template preparation kit (Roche Diagnostics GmbH, Mannheim,
Germany), following the manufacturer’s instructions. The DNAwas stored at −20°C until used.
2.5. Polymerase chain reaction
PCR analysis of kDNA for subgenus Leishmania was carried out by using the AJS1 and DeB8
primers [13]. PCR of the L. mexicana complex was carried out using the M1 and M2 primers
[14] and the LMO1 and LMO2 primers specific for minicircles of Mexican L. (L.) mexicana
strains [15]). PCR of the L. braziliensis complex was done with the B1 and B2 primers [8]. PCR
for L. donovani complex was done with the D1 and D2 primers [16]. PCR amplification condi-
tions were performed as described previously [8, 13, 14, 16, 17].
2.6. PCR analysis of genomic DNA of L. (V.) braziliensis
PCR species specific for nuclear DNA from variants of L. (V.) braziliensis was carried out by
using the primers 3J1 and 3J2. Amplification conditions were as described elsewhere [18].
2.7. PCR analysis of the internal transcribed spacer 1 (ITS1)
Some samples were analyzed for ITS1 PCR using the primers: LITSR and L5.8S [10]. Amplifi-
cation conditions were as described [12]. PCR products were digested with HaeIII enzyme,
Number Strain Code Leishmania species
1 MHOM/BZ/82/BEL21 BEL21 L. (L.) mexicana
2 MHOM/BZ/62/M379 M379 L. (L.) mexicana
3 IFLA/BR/67/PH8 PH8 L. (L.) amazonensis
4 MHOM/BR/73/M2269 M2269 L. (L.) amazonensis
5 MHOM/PE/84/LC53 LC53 L. (V.) braziliensis
6 MHOM/BR/84/LTB300 LTB300 L. (V.) braziliensis
7 MHOM/BR/75/M2903 M2903 L. (V.) braziliensis
8 MHOM/BR/75/M2904 M2904 L. (V.) braziliensis
9 MHOM/BR/75/M4147 M4147 L. (V.) guyanensis
10 MHOM/PE/84/LC26 LC26 L. (V.) peruviana
11 MHOM/CR/87/NEL3 NEL3 L. (V.) panamensis
12 MHOM/PA/72/LS94 LS94 L. (V.) panamensis
13 MHOM/IN/80/DD8 DD8 L. (L.) donovani
14 MHOM/BR/74/PP75 PP75 L. (L.) infantum/chagasi
Table 1. Reference strains used in this study.
The Epidemiology and Ecology of Leishmaniasis156
according to the manufacturer’s instructions. The amplicons and restriction products were
analyzed as described elsewhere [12].
2.8. Southern or dot blot hybridization of kDNA PCR products of biopsies, isolates
and Leishmania reference strains
The kDNA PCR products of clinical samples, Mexican isolates and reference strains, were
Southern or dot blotted onto nylon membranes and were hybridized with the cloned frag-
ments of kDNA used as probes: B4Rsa, which hybridizes specifically to members of the L.
donovani complex; 9.2 and 9.3, specific for the L. mexicana complex; and B18, specific for
members of the L. braziliensis complex. The probes were labeled with DIG Random Primer
DNA labeling kit (Boehringer Mannheim) and either visualized colorimetrically with NBT and
BCIP (Boehringer Mannheim) or labeled with [32P]d ATP, using the Prime-it™ Random Primer
DNA labeling kit (Stratagene). The hybridization conditions were described elsewhere [14, 17].
2.9. Administration of meglumine antimoniate (Glucantime®)
Patients diagnosed with CL accepted treatment with meglumine antimoniate (Glucantime®).
Glucantime is marketed in 5 mL ampules containing 1.5 g of N-methyl-glucamine antimoniate,
which corresponds to 425 mg of Sb51. Treatment consisted in one ampule by intramuscular
injection per day until healing [19].
Number Code Origin Clinical expression Leishmania species
1 MHOM/MX/88/HRC JS Tabasco DCL L. am + L. mex
2 MHOM/MX/88/HRC MC Tabasco LCL L. (L.) mexicana
3 MHOM/MX/84/ISET GS Tabasco DCL L. am + L. mex
4 MHOM:MX:83:UAVY CV Yucatan LCL L. (L.) mexicana
5 MHOM/MX/85/ISET HF Veracruz DCL L. am + L. mex
6 LVER Veracruz DCL L. am + L. mex
7 REP Campeche LCL L. am + L. mex
8 MHM/MX/06/ENCB/MIC Campeche LCL L. (L.) mexicana
9 MHM/MX/06/ENCB CDL Campeche LCL L. (L.) mexicana
10 MHM/MX/06/ENCB FDL Campeche LCL L. (L.) mexicana
11 CR Campeche LCL L. (V.) braziliensis
12 PVS Campeche LCL Mx. L. mexicana
13 RGL Campeche LCL L. b + L. mx
14 FJJ Campeche LCL L. b + L. mx
15 ESP Campeche LCL Mx. L. mexicana
L. am + L. mex, L. (L.) amazonensis + L. (L.) mexicana; L. b + L. mx, L. braziliensis + L. mexicana; Mx. L. mexicana, Mexican
variant of L. (L.) mexicana
Table 2. Mexican isolates of Leishmania analyzed in this study.
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3. Results
Primers DeB8 and AJS1, specific for the Leishmania (L.) subgenus [13], amplified the kDNA of
L. (L.) mexicana Bel 21, L. (L.) mexicanaM379, L. (L.) amazonensis PH8, L. (L.) amazonensisM2269,
L. (L.) donovani DD8, L. (L.) infantum/chagasi PP75, 10 Mexican strains of Leishmania, and many
clinical samples from patients with skin lesion from Campeche, Tabasco, Veracruz, and
Quintana Roo (Tables 1 and 2, Figure 1) [17].
PCR with the primers M1 and M2 specific for the L. mexicana complex [14] resulted in the
amplification of kDNA of L. (L.) amazonensis PH8 and M2269 with a band size of 700 bp and L.
(L.) mexicana BEL21 with a band size of 800–820 bp. This difference can be used diagnostically
to distinguish between L. (L.) amazonensis and L. (L.) mexicana isolates. The size of the kDNA
amplicons of the Mexican strains is more similar to the size of the amplicons of L. (L.)
amazonensis group than the amplicons of L. (L.) mexicana. Negative controls, T. cruzi and M.
tuberculosis, did not amplify [17].
PCR specific for the L. braziliensis complex carried out with B1 and B2 primers [8] produced a
kDNA amplification band of 750 bp of L. (V.) braziliensis LTB300, LC53, L. (V.) braziliensis
M2903, L. (V.) braziliensis M2904, L. (V.) braziliensis reference strains, and some skin biopsies
from Nayarit and several skin samples from Campeche state.
In order to have a more accurate identification of the Leishmania species in Nayarit, the skin
biopsies were PCR analyzed with primers 3J1 and 3J2 specific for DNA genomic of L. (V.)
braziliensis.Most of the samples amplified giving a band of 617 bp. The PCR products hybridized
positively with the LbJ38 probe, which is species specific for L. braziliensis complex [18, 20].
PCR with specific primers D1 and D2 for the L. donovani complex resulted in the amplification
of kDNA of the L. (L.) donovani DD8 and L. (L.) infantum/chagasi PP75 reference strains, and
bone marrow and liver biopsy from a patient from Chiapas with VL were amplified [16, 21].
PCR products of the kDNA of Mexican strains of Leishmania mexicana and clinical samples
amplified with primers AJS1 and DeB8, specific for the subgenus Leishmania, were dot blotted
and tested with probe 9.2, specific for the L. mexicana complex. The probe hybridized with high
affinity to L. (L.) mexicana BEL21, the 10 Mexican strains of Leishmania mexicana, several
samples and biopsies from Campeche state, and DNA from a bone marrow aspirate, from a
patient from Tabasco, with VL; kDNA from the reference strains other than L. mexicana that
did not hybridize.
PCR products amplified with primers B1 and B2, specific for the L. braziliensis complex, were
Southern blotted and tested with probe B18, specific for the L. braziliensis complex. This probe
hybridized to L. (V.) braziliensis LTB300 and to DNA from skin biopsies from patients from
Campeche and some from Nayarit states (Figure 1) [20].
PCR with specific primers for ITS1 resulted in the amplification of the Leishmania reference
strains, the Mexican strains and isolates of L. mexicana, and the clinical samples from Campe-
che giving 300–350 bp amplification bands. Restriction of the ITS1 gene amplicons of L. (V.)
panamensis, L. (V.) guyanensis, and L. (L.) braziliensis reference strains with the endonuclease
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HaeIII generated patterns with two bands of 170 and 150 bp; L. (L.) amazonensis generated two
bands of 220 and 140 bp; and L. mexicana generated three bands of 200, 80, and 40 bp.
Most of the Mexican strains and isolates of Leishmania displayed a restriction pattern similar to
that of L. (L.) mexicana reference strain; nine of these were obtained from LCL patients from
Campeche. Some showed a mixed pattern compatible with L. (L.) mexicana and L. (V.)
braziliensis; some others showed a mixed pattern compatible with L. (L.) amazonensis and L.
(L.) mexicana (Table 2) [11].
In relation to the clinical samples from Campeche, most of them amplified a restriction pattern
similar to the L. (L.) mexicana reference strain. In some samples, extra bands of 50 and 25 bp
were observed, suggesting a coinfection, as it was found in a previous study with kDNA PCR
analysis of clinical samples that DNA from both L. (L.) mexicana and L. (V.) braziliensis was
identified (Table 2) [11, 15].
4. Discussion
In Mexico since 1985, cases of LCL, DCL, MCL, and VL clinical expressions were reported in 15
states; the species involved were L. (L.) mexicana, L. (V.) braziliensis, and L. (L.) chagasi. LCL was
the most common, and all cases were considered caused by L. (L.) mexicana [6, 22]. The five
major foci of Leishmania transmission were in rain forest of southern Campeche, La Chontalpa
(the cocoa-producing district of Tabasco), and the southern coffee producing of Nayarit, south-
ern Quintana Roo, and Chiapas (Figure 1).
In Nayarit, state of the Pacific endemic region, LCL was recorded in Caleras de Cofrados since
1987 [22], a district near Tepic, the state capital city (Figure 1). The etiological agent was
thought to be L. (L.) mexicana. In our studies using kDNA PCR and hybridization techniques,
we have demonstrated that the L. braziliensis complex is present in Nayarit, and we were able
to distinguish between two variants or two different species of L. (V.) braziliensis. We believe
this was the first report of L. (V.) braziliensis in Nayarit, Mexico [20]. The population affected
with skin lesion were 5–65 years old; males were the most affected and their main activity was
the harvesting and/or growing coffee. The possible vectors are Lutzomyia cruciata, Lutzomyia
diabolica, and Lutzomyia shannoni, which were captured and identified at the plantation. In
relation with the animal reservoirs, no studies have been reported [20].
Biopsies, clinical samples, and isolates from LCL patients from several districts of Campeche
state, mainly from Calakmul, were PCR amplified with specific primers for kDNA of L.
braziliensis and L. mexicana complex members and primers specific for Mexican strains of L.
mexicana [19] and also were analyzed by ITS1 PCR-RFLP [12]. We detected in Northern
Calakmul 43% of cases infected with L. mexicana, 25% of cases with L. braziliensis complex
members, 62% of mixed infection of Mx L. mexicana + L. (L.)mexicana, and 25% of cases infected
with L. braziliensis complex + L. (L.) mexicana. The most affected community of this area was La
Mancolona, with a 6.5% of prevalence; this village is located 3–4 km away from the crops and
is more urbanized due to deforestation (Figure 3a). The most affected population in this village
were adult males (66%) [19].
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In central Calakmul 15% of the cases were infected with L. (L.) mexicana, 25% of the cases
infected with L. braziliensis complex members, and 37% of the cases infected with Mx L.
mexicana L. (L.) mexicana. La Guadalupe village had the highest prevalence rate (2.2%) and
children were the most affected (67%) [19].
In southern Calakmul 25% of the cases were infected with L. (L.) mexicana, 62% with L.
braziliensis complex members, and 75% with both L. (L.) mexicana and L. braziliensis complex
members. Dos Lagunas Sur was the most affected community, located close to the border with
Belize, with 12% prevalence (Figure 2c). People in this village farm chili crops around their
houses, which are located very close to the forest, and the population affected were children
(50%), women, and men (50%) (Figures 2a–c and 3a–c) [19]. In relation to the vectors, L.
mexicana infections in two sand fly species, Lu. shannoni and Lutzomyia ylephiletor, were found
in Dos Lagunas Sur, whereas in La Mancolona, L. (L.) mexicana infections were found in Lu.
shannoni, Lu. cruciata, Lu. o. olmeca, and Lu. Panamensis [23].
Regarding to the animal reservoirs, L. (L.) mexicana was identified in four species of wild
rodents: the black-eared rice rat, Oryzomys melanotis; the hispid cotton-rat, Sigmodon hispidus;
the big-eared climbing rat, Ototylomys phyllotis; and the Yucatan deer mouse, Peromyscus
yucatanicus [24].
We found most of the cases of DCL in the states of Tabasco and Veracruz (Figure 1). These
states have a common border in the endemic region of the Gulf of Mexico and are
Figure 2. Patients from the endemic Gulf of Mexico region, with skin lesions suffering from cutaneous leishmaniasis.
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characteristically tropical rain forest, with considerable rainfall and important agricultural
activities, including the production of cocoa, sugar cane, and rubber. We collected isolates
from patients with DCL or LCL in these states and some from Campeche. Their DNA was
amplified with primers M1 and M2 [17] specific for kDNA of L. mexicana complex. The size of
PCR products (680–720 bp) of the Mexican isolates is more similar to the size of the PCR
products (700 bp) of L. (L.) amazonensis group than the PCR products (800–820 bp) of L. (L.)
mexicana BEL21. The isolate PCR products hybridized with probe 9.2 specific for the L.
mexicana complex. Their DNA was also analyzed using ITS1 PCR-RFLP, and we confirmed
the presence of both DNA of L. (L.) amazonensis and L. (L.)mexicana in the same isolate (Table 2)
[12, 17].
In Mexico, it has been reported that VL was caused by L. (L.) chagasi and confined to Central
endemic region [22]. Subsequently, in the Pacific endemic region states of Chiapas, Guerrero
VL was detected. In Tabasco, only cases of LCL and DCL caused by L. (L.) mexicana have
previously been reported [25]. In our studies by kDNA analysis, we have found VL cases in
Tabasco (a 6-month-old immunosuppressed male) [21] and in Chiapas (a 36-year-old male
coinfected with HIV and Pneumocystis carinii) to be caused by L. (L.) mexicana [26]. These
findings are important because it indicates that these species, typically cutaneous, can
visceralize in immunocompromised patient, and in Mexico, MCL, LCL, and VL coexist in
Figure 3. Communities situated in the leishmaniasis endemic region of Gulf of Mexico. People in these villages farm chili
crops around their houses, located very near the forest close to the border of Belize and Guatemala.
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some endemic areas. This is the first case reported in Mexico of coinfection by L. (L.) mexicana
and HIV, which was manifested as VL. Our results agree with those found in Hernandez
[26], who reported in Venezuelan patient displaying the symptoms of VL, a coinfection with
HIV and a Leishmania variant strain sharing kDNA sequences with L. braziliensis and L.
mexicana [27].
Treatment of CL patients with Glucantime® was successful in 96% of cases, regardless of the
number and location of lesions. To obtain complete healing of lesions, the doses needed were
in children from 2 to 20 and in adults from 2 to 67 ampules, although some patients cure
spontaneously [19].
In the endemic areas evaluated in the present studies, the risk factors associated with CL
were identified as the human colonization of large areas of previously untouched rain
forests, where CL is endemic. The urbanization and deforestation are important factors
because the Leishmania transmission cycles are adapting to peridomestic environments and
are spreading to previously no endemic areas with domestic animals as potential reservoirs
and spending nocturnal periods in the forest for cultivation of agricultural crops (e.g., chili
and coffee) (Figure 3a–d) [11, 19, 20].
5. Conclusion
In conclusion, our findings are interesting because we have shown that in the typical endemic
regions of Gulf of Mexico and Ocean Pacific of Mexico, CL can be caused by several species of
the L. mexicana and L. braziliensis complexes and in some clinical samples, we found DNA of
both complexes. Furthermore, we found DCL caused by a mix infection with strains of L. (L.)
amazonensis and L. (L.) mexicana [12], both belonging to the L. mexicana complex. VL can be
caused by L. (L.) chagasi and in immunocompromised patients by L. (L.) mexicana. Diagnosis of
leishmaniasis by PCR and hybridization of kDNA and ITS1 PCR-RFLP analysis of Leishmania
DNA must be combined for the reliable characterization of Leishmania species mainly in
endemic areas where the presence of multiple species of Leishmania overlap clinical pictures
demands simultaneous species identification [12]. In Mexico, the geographic range in which
CL is endemic has increased in size due to urbanization, new settlements, and ecological,
social, and educative conditions, which favors its permanence and transmission, as it has
occurred in Calakmul.
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